JP5662794B2 - Water-in-oil emulsion composition - Google Patents
Water-in-oil emulsion composition Download PDFInfo
- Publication number
- JP5662794B2 JP5662794B2 JP2010284659A JP2010284659A JP5662794B2 JP 5662794 B2 JP5662794 B2 JP 5662794B2 JP 2010284659 A JP2010284659 A JP 2010284659A JP 2010284659 A JP2010284659 A JP 2010284659A JP 5662794 B2 JP5662794 B2 JP 5662794B2
- Authority
- JP
- Japan
- Prior art keywords
- water
- viscosity
- oil
- emulsion composition
- oil emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 78
- 239000007762 w/o emulsion Substances 0.000 title claims description 43
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 20
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 claims description 20
- 239000011734 sodium Substances 0.000 claims description 20
- 229910052708 sodium Inorganic materials 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 10
- 239000002738 chelating agent Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 5
- 238000005259 measurement Methods 0.000 claims description 4
- 229940031709 peg-30-dipolyhydroxystearate Drugs 0.000 claims description 3
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical class CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 25
- 239000003921 oil Substances 0.000 description 23
- 230000000052 comparative effect Effects 0.000 description 21
- 238000003860 storage Methods 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 17
- 239000004205 dimethyl polysiloxane Substances 0.000 description 14
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 14
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 13
- 229940008099 dimethicone Drugs 0.000 description 13
- 239000012071 phase Substances 0.000 description 13
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 12
- 150000005846 sugar alcohols Polymers 0.000 description 12
- 239000002562 thickening agent Substances 0.000 description 12
- 150000002148 esters Chemical class 0.000 description 10
- -1 polyoxyethylene Polymers 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 229920006037 cross link polymer Polymers 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 6
- 229920002554 vinyl polymer Polymers 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003792 electrolyte Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- JJOJFIHJIRWASH-UHFFFAOYSA-N icosanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCCCCCCC(O)=O JJOJFIHJIRWASH-UHFFFAOYSA-N 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000001488 sodium phosphate Substances 0.000 description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 229940043375 1,5-pentanediol Drugs 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 3
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- 229960005066 trisodium edetate Drugs 0.000 description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- DCVMAYAWOPBYKB-UHFFFAOYSA-N 3-[methyl(tetradecanoyl)amino]propanoic acid Chemical compound CCCCCCCCCCCCCC(=O)N(C)CCC(O)=O DCVMAYAWOPBYKB-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 150000000996 L-ascorbic acids Chemical class 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- PUGFCQQOYJMKOO-UHFFFAOYSA-N n-(3-hexadecoxy-2-hydroxypropyl)-n-(2-hydroxyethyl)hexadecanamide Chemical compound CCCCCCCCCCCCCCCCOCC(O)CN(CCO)C(=O)CCCCCCCCCCCCCCC PUGFCQQOYJMKOO-UHFFFAOYSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- JSOVGYMVTPPEND-UHFFFAOYSA-N 16-methylheptadecyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)(C)C JSOVGYMVTPPEND-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- QOOALSWUUBYFCT-UHFFFAOYSA-N 2-[2-(7-methyloctanoyloxy)propoxy]propyl 7-methyloctanoate Chemical compound CC(C)CCCCCC(=O)OCC(C)OCC(C)OC(=O)CCCCCC(C)C QOOALSWUUBYFCT-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- BXCRLBBIZJSWNS-UHFFFAOYSA-N 2-hydroxyethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCO BXCRLBBIZJSWNS-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- JAUFWPNLLLUYNV-UHFFFAOYSA-N 3-(16-methylheptadecoxy)propane-1,2-diol Chemical compound CC(C)CCCCCCCCCCCCCCCOCC(O)CO JAUFWPNLLLUYNV-UHFFFAOYSA-N 0.000 description 1
- DJMBNBIFHBZPFR-UHFFFAOYSA-N 3-(7-methyloctanoyloxy)butyl 7-methyloctanoate Chemical compound C(CCCCCC(C)C)(=O)OCCC(C)OC(CCCCCC(C)C)=O DJMBNBIFHBZPFR-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- KIENGQUGHPTFGC-JLAZNSOCSA-N L-ascorbic acid 6-phosphate Chemical compound OP(=O)(O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O KIENGQUGHPTFGC-JLAZNSOCSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- IRJHMGSFUSXXQJ-JBEKKHDOSA-K trisodium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O IRJHMGSFUSXXQJ-JBEKKHDOSA-K 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、油中水型乳化組成物の技術分野に関する。 The present invention relates to the technical field of water-in-oil emulsion compositions.
多価アルコールのポリ(12−ヒドロキシステアリン酸)エステルは、低粘度の化粧料を調製でき、それ自身は軽い感触でべたついたりしないので、とかく油っぽく重たい使用感になりがちな油中水型乳化組成物の乳化剤として広く使用されている。
しかしながら、特徴である「低粘度」は、ともすると高温安定性を損なう場合や、剤型のバリエーション化が出来ずに単調な製品になる場合があった。
一般的に、組成物の粘度を高めるために親水性や親油性の増粘剤を配合することが知られており、多価アルコールのポリ(12−ヒドロキシステアリン酸)エステルを用いた油中水型乳化組成物にも配合されている。
例えば、ジポリヒドロキシステアリン酸ポリオキシエチレンと、1,1−メチレン−ビス(4−イソシアネートシクロヘキサン)ポリプロピレングリコール共重合体とを組み合わせる技術が開示されている(特許文献1:特開2002−308962号公報)。しかしながら、1,1−メチレン−ビス(4−イソシアネートシクロヘキサン)ポリプロピレングリコール共重合体は塗布した皮膚に被膜を形成するので、組成物の粘度は高くなるものの使用感が悪くなる場合があった。
また、油中水型乳化組成物に電解質を配合すると、安定性が良好になることが知られている(特許文献:特開2003−286125号公報)。しかしながら、電解質では粘度を高める効果は低く、電解質の配合は補助的な手段であった。
一般に液体の粘度は,温度によって大きく変化するものであるが、温度変化に対する粘度変化が小さいことは、使用時の環境(外気温が低い、或いは高い)に影響されずに、常に一定の使い心地を提供できるので好ましいことである。
多価アルコールのポリ(12−ヒドロキシステアリン酸)エステルを使用した油中水型乳化組成物の粘度を高め、しかも温度変化に対する粘度変化が小さい組成物を作製する技術が求められている。
Poly (12-hydroxystearic acid) esters of polyhydric alcohols can be used to prepare low-viscosity cosmetics and themselves do not stick to the light feel, so anyway they tend to be greasy and heavy to use. Widely used as an emulsifier in emulsified compositions.
However, the characteristic “low viscosity” sometimes impairs the stability at high temperature, and sometimes the dosage form cannot be varied, resulting in a monotonous product.
In general, it is known to add a hydrophilic or lipophilic thickener to increase the viscosity of the composition, and water-in-oil using a poly (12-hydroxystearic acid) ester of a polyhydric alcohol. It is also blended in the mold emulsion composition.
For example, a technique of combining polyoxyethylene dipolyhydroxystearate and 1,1-methylene-bis (4-isocyanatecyclohexane) polypropylene glycol copolymer is disclosed (Patent Document 1: Japanese Patent Application Laid-Open No. 2002-308962). Publication). However, since 1,1-methylene-bis (4-isocyanatecyclohexane) polypropylene glycol copolymer forms a film on the applied skin, the viscosity of the composition increases, but the usability may be deteriorated.
In addition, it is known that when an electrolyte is blended in a water-in-oil emulsion composition, stability is improved (Patent Document: JP-A-2003-286125). However, the effect of increasing the viscosity is low in the electrolyte, and the blending of the electrolyte was an auxiliary means.
In general, the viscosity of a liquid varies greatly depending on the temperature. However, the small change in viscosity with respect to the temperature change is not affected by the environment (low or high outside temperature) during use, and is always constant. This is preferable.
There is a need for a technique for increasing the viscosity of a water-in-oil emulsion composition using a poly (12-hydroxystearic acid) ester of a polyhydric alcohol and producing a composition having a small viscosity change with respect to a temperature change.
多価アルコールのポリ(12−ヒドロキシステアリン酸)エステルを用いた油中水型乳化組成物を増粘させることを課題とする。 It is an object to increase the viscosity of a water-in-oil emulsion composition using a poly (12-hydroxystearic acid) ester of a polyhydric alcohol.
本発明の主な構成は、次のとおりである。
(1)成分(A)としてジポリヒドロキシステアリン酸PEG−30、成分(B)としてトコフェリルリン酸ナトリウムを含有することを特徴とする油中水型乳化組成物。
(2)さらに成分(C)として、キレート剤を含有することを特徴とする(1)に記載の油中水型乳化組成物。
(3)測定温度25℃において、B型粘度計、4号ローター、12rpm、30秒間撹拌による粘度が、5000〜22000mPa・sの範囲にあることを特徴とする(1)又は(2)に記載の油中水型乳化組成物。
(3)成分(A)ジポリヒドロキシステアリン酸PEG−30の配合量は0.1〜5質量%、成分(B)トコフェリルリン酸ナトリウムの配合量は0.1〜10質量%であることを特徴とする(1)〜(3)のいずれかに記載の油中水型乳化組成物。
The main configuration of the present invention is as follows.
(1) A water-in-oil emulsion composition comprising PEG-30 dipolyhydroxystearate as the component (A) and sodium tocopheryl phosphate as the component (B).
(2) The water-in-oil emulsion composition according to ( 1) , further comprising a chelating agent as the component (C).
(3) The viscosity measured by stirring for 30 seconds at a measurement temperature of 25 ° C. in a B-type viscometer, No. 4 rotor, 12 rpm, 12 seconds is in the range of 5000 to 22000 mPa · s, as described in (1) or (2) A water-in-oil emulsion composition.
(3) The blending amount of component (A) dipolyhydroxystearic acid PEG-30 is 0.1 to 5% by weight, and the blending amount of component (B) sodium tocopheryl phosphate is 0.1 to 10% by weight. The water-in-oil emulsion composition according to any one of (1) to ( 3) .
多価アルコールのポリ(12−ヒドロキシステアリン酸)エステルで乳化した油中水型乳化組成物に、トコフェリルリン酸ナトリウムを含有させることで、その組成物の粘度を特異的に著しく高めることができる。したがって、多価アルコールのポリ(12−ヒドロキシステアリン酸)エステルで乳化した油中水型乳化組成物の、処方のバリエーション化が容易となる。
すなわち、さっぱりとしたべたつかない使用感を維持しながら、粘性を高め、製剤を塗布する際の、高級なクリーム状の使用感を実現することができる。
本発明の油中水型乳化組成物は、保存安定性に優れる。
本発明の構成をとる油中水型乳化組成物の、各保存温度(5℃〜50℃)における粘度の差は、製品化した時の品質上、問題のないレベルである。
さらに任意にキレート剤を含有させることにより、保存温度による粘度の差を著しく小さくすることが可能である。
したがって、使用時の環境(外気温が低い、或いは高い)に影響されずに、常に一定の使用感(粘度)の皮膚外用剤を提供できる。本発明の油中水型乳化組成物はごわつきなどのない優れた使用感である。
By including sodium tocopheryl phosphate in a water-in-oil emulsion composition emulsified with poly (12-hydroxystearic acid) ester of polyhydric alcohol, the viscosity of the composition can be significantly increased. . Therefore, the formulation of the water-in-oil emulsion composition emulsified with poly (12-hydroxystearic acid) ester of polyhydric alcohol can be easily varied.
That is, while maintaining a refreshing and non-sticky feeling, it is possible to increase the viscosity and realize a high-grade creamy feeling when applying the preparation.
The water-in-oil emulsion composition of the present invention is excellent in storage stability.
The difference in the viscosity at each storage temperature (5 ° C. to 50 ° C.) of the water-in-oil emulsion composition having the configuration of the present invention is a level with no problem in terms of quality when commercialized.
Furthermore, by arbitrarily containing a chelating agent, it is possible to significantly reduce the difference in viscosity depending on the storage temperature.
Therefore, it is possible to provide a skin external preparation having a constant feeling of use (viscosity) without being affected by the environment during use (the outside air temperature is low or high). The water-in-oil emulsified composition of the present invention has an excellent feeling of use without being stiff.
本発明の(A)成分である多価アルコールのポリ(12−ヒドロキシステアリン酸)エステルは、多価アルコールをアルカリ存在下、ポリ(12−ヒドロキシステアリン酸)に、塩化チオニル等のハロゲン化剤を反応させて調製した、酸クロライドを反応させることにより得ることができる。
多価アルコ−ルとしては、プロピレングリコール、ブタンジオール、ペンタンジオール、(ポリ)グリセリン、(ポリ)プロピレングリコール、ポリエチレングリコールなどが好ましく例示でき、ポリエチレングリコールが特に好ましい。この場合のポリエチレングリコールのサイズは、平均分子量で400〜6000が好ましい。一方、疎水基となるポリ(12−ヒドロキシステアリン酸)は、そのサイズが平均分子量1000〜3000であることが好ましい。
ポリエチレングリコールのジ(12−ヒドロキシステアリン酸)エステルを用いることが好ましく、INCI名がジポリヒドロキシステアリン酸PEG−30と収載されているものが好ましく、市販品としては、ユニケマ社製のアラセルP−135、クローダジャパン(株)社製のシスロールDPHS等が挙げられる。
本発明の(A)成分である多価アルコールのポリ(12−ヒドロキシステアリン酸)エステルの配合量は、0.1〜5質量%が好ましく、特に好ましくは1〜5質量%である。0.1質量%に満たないと、乳化が不十分になる場合ある。5質量%を超えると、べたついた使用感になる場合がある。
The poly (12-hydroxystearic acid) ester of the polyhydric alcohol which is the component (A) of the present invention is prepared by adding a halogenating agent such as thionyl chloride to the poly (12-hydroxystearic acid) in the presence of alkali. It can be obtained by reacting acid chloride prepared by reaction.
Preferred examples of the polyhydric alcohol include propylene glycol, butanediol, pentanediol, (poly) glycerin, (poly) propylene glycol, and polyethylene glycol, with polyethylene glycol being particularly preferred. In this case, the polyethylene glycol preferably has an average molecular weight of 400 to 6000. On the other hand, the poly (12-hydroxystearic acid) serving as a hydrophobic group preferably has an average molecular weight of 1000 to 3000.
It is preferable to use di (12-hydroxystearic acid) ester of polyethylene glycol, and those whose INCI name is listed as dipolyhydroxystearic acid PEG-30 are preferable. 135, Cisroll DPHS manufactured by Croda Japan Co., Ltd., and the like.
The blending amount of the poly (12-hydroxystearic acid) ester of the polyhydric alcohol which is the component (A) of the present invention is preferably from 0.1 to 5% by mass, particularly preferably from 1 to 5% by mass. If it is less than 0.1% by mass, emulsification may be insufficient. If it exceeds 5 mass%, a sticky feeling may be obtained.
本発明の(B)成分であるトコフェリルリン酸ナトリウムは、トコフェロール(ビタミンE)のリン酸エステルのナトリウム塩である。白色から微黄色の粉末状で、室温で水に容易に溶解する。溶液の性状は、2質量%水溶液でPH9.0〜10.0、粘度は100mPa・s以下(B型粘度計、1号ローター、12rpm、30秒、25℃測定)である。
ビタミンEは脂溶性ビタミンとして有用なビタミンであり、ビタミンCなどの水溶性抗酸化化合物と協同して紫外線などにより惹起される酸化ストレスから皮膚を守る働きを持つ。トコフェリルリン酸ナトリウムは、ビタミンEそれ自体が化学的に不安定なことから誘導体化したものである。トコフェリルリン酸ナトリウムは、皮膚内の脱リン酸化酵素によりビタミンEに変換され、抗酸化作用や抗炎症作用を発揮して肌荒れを改善するので、その美容効果を期待して化粧料などの皮膚外用剤に配合される。
市販されている昭和電工株式会社製の「ビタミンEリン酸ナトリウム」を用いることができる。
本発明において、トコフェリルリン酸ナトリウムは、美容効果を発揮するだけでなく、多価アルコールのポリ(12−ヒドロキシステアリン酸)エステルで乳化した油中水型乳化組成物の粘度を調節する働きをする。これは特異的な現象である。
多価アルコールのポリ(12−ヒドロキシステアリン酸)エステルで乳化した油中水型乳化組成物の粘度を高めるためには、油中水型乳化組成物に対して0.1〜10質量%含有させることが好ましく、より好ましくは0.5〜6質量%含有させることが好ましい。
0.1質量%に満たないと、本発明の乳化組成物の増粘効果に十分寄与することができない恐れがある。10質量%を超えると不経済である。
The tocopheryl sodium phosphate which is the component (B) of the present invention is a sodium salt of a phosphate ester of tocopherol (vitamin E). It is a white to slightly yellow powder and easily dissolves in water at room temperature. The solution has a pH of 9.0 to 10.0 in a 2% by mass aqueous solution and a viscosity of 100 mPa · s or less (B-type viscometer, No. 1 rotor, 12 rpm, 30 seconds, measured at 25 ° C.).
Vitamin E is a useful vitamin as a fat-soluble vitamin, and has the function of protecting the skin from oxidative stress caused by ultraviolet rays in cooperation with water-soluble antioxidant compounds such as vitamin C. Sodium tocopheryl phosphate is derivatized because vitamin E itself is chemically unstable. Sodium tocopheryl phosphate is converted into vitamin E by dephosphorylating enzyme in the skin, and it exhibits antioxidant and anti-inflammatory effects to improve rough skin. It is blended in an external preparation.
Commercially available “Vitamin E sodium phosphate” manufactured by Showa Denko KK can be used.
In the present invention, sodium tocopheryl phosphate not only exhibits a cosmetic effect, but also functions to adjust the viscosity of a water-in-oil emulsion composition emulsified with a poly (12-hydroxystearic acid) ester of a polyhydric alcohol. To do. This is a unique phenomenon.
In order to increase the viscosity of the water-in-oil emulsion composition emulsified with poly (12-hydroxystearic acid) ester of polyhydric alcohol, 0.1 to 10% by mass is contained with respect to the water-in-oil emulsion composition. It is preferable to contain 0.5 to 6% by mass.
If it is less than 0.1% by mass, it may not be able to sufficiently contribute to the thickening effect of the emulsion composition of the present invention. When it exceeds 10 mass%, it is uneconomical.
本発明の油中水型乳化組成物の粘度は5000〜22000mPa・s(B型粘度計、4号ローター、12rpm、30秒、25℃測定)の範囲にあることが好ましい。 The viscosity of the water-in-oil emulsion composition of the present invention is preferably in the range of 5000 to 22000 mPa · s (B-type viscometer, No. 4 rotor, 12 rpm, 30 seconds, 25 ° C. measurement).
本発明の油中水型乳化組成物に、さらに成分(C)としてキレート剤を含有させると、油中水型乳化組成物の保管温度による粘度の差をより小さくすることが出来るので好ましい。
キレート剤としては、エデト酸二ナトリウム、エデト酸三ナトリウム、エデト酸四ナトリウム、エデト酸二カリウムを例示することができる。エデト酸三ナトリウムを用いることが好ましい。市販されているキレスト株式会社製のキレスト2C-SDを用いることができる。
油中水型乳化組成物は、キレート剤を0.0001質量%〜0.2質量%含有することが好ましい。
It is preferable to add a chelating agent as the component (C) to the water-in-oil emulsion composition of the present invention, since the difference in viscosity depending on the storage temperature of the water-in-oil emulsion composition can be further reduced.
Examples of the chelating agent include disodium edetate, trisodium edetate, tetrasodium edetate, and dipotassium edetate. It is preferable to use trisodium edetate. A commercially available Kirest 2C-SD manufactured by Kirest Co., Ltd. can be used.
The water-in-oil emulsion composition preferably contains 0.0001% by mass to 0.2% by mass of a chelating agent.
本発明の油中水型乳化組成物には、任意成分として本発明の効果を損なわない範囲で、化粧料に通常用いられている成分、例えば、非イオン性界面活性剤、陰イオン性界面活性剤、陽イオン性界面活性剤、両性界面活性剤、油剤、多価アルコール等の保湿剤、増粘剤、抗酸化剤、紫外線吸収剤、塩類、PH調整剤、防腐剤、抗菌剤、着色剤、香料等を配合することができる。また、アスコルビン酸誘導体、セラミド、植物抽出液等の美容成分を配合することができる。 In the water-in-oil emulsion composition of the present invention, components that are usually used in cosmetics, for example, nonionic surfactants, anionic surfactants, as long as the effects of the present invention are not impaired as optional components Agents, cationic surfactants, amphoteric surfactants, oil agents, polyhydric alcohols and other moisturizers, thickeners, antioxidants, UV absorbers, salts, pH modifiers, antiseptics, antibacterial agents, colorants Perfumes and the like can be blended. In addition, cosmetic ingredients such as ascorbic acid derivatives, ceramides, and plant extracts can be blended.
油剤としては、エステル油、植物油のような油脂類、炭化水素類、高級脂肪酸、高級アルコール、シリコ−ン油などが例示できる。
エステル油としては、例えば、エチルヘキサン酸セチル、ジイソノナン酸1,3−ブチレングリコール、ジ2−エチルヘキサン酸1,3−ブチレングリコール、ジイソノナン酸ジプロピレングリコール、ジ2−エチルヘキサン酸ジプロピレングリコール、イソノナン酸イソノニル、トリ2−エチルヘキサン酸グリセリル、トリカプリン酸グリセリル、トリイソステアリン酸グリセリル、ジカプリン酸ネオペンチルグリコール、パルミチン酸エチルヘキシル、ネオペンタン酸イソステアリル等が挙げられる。
油脂類としては、例えば、ツバキ油、月見草油、マカデミアナッツ油、オリーブ油、ナタネ油、トウモロコシ油、ゴマ油、ホホバ油、胚芽油、小麦胚芽油、等の液体油脂、カカオ脂、ヤシ油、硬化ヤシ油、パーム油、パーム核油、モクロウ、モクロウ核油、硬化油、硬化ヒマシ油等の固体油脂、ミツロウ、キャンデリラロウ、綿ロウ、ヌカロウ、ラノリン、酢酸ラノリン、液状ラノリン、サトウキビロウ等のロウ類が挙げられる。
炭化水素類としては、例えば、流動パラフィン、スクワレン、スクワラン、マイクロクリスタリンワックス等が挙げられる。
高級脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、リノール酸、リノレン酸、ドコサヘキサエン酸(DHA)、エイコサペンタエン酸(EPA)等が挙げられる。
高級アルコールとしては、例えば、ラウリルアルコール、ステアリルアルコール、セチルアルコール、セトステアリルアルコール等の直鎖アルコール、モノステアリルグリセリンエーテル、ラノリンアルコール、コレステロール、フィトステロール、オクチルドデカノール等の分枝鎖アルコール等が挙げられる。
シリコ−ン油として、例えば、鎖状ポリシロキサンのジメチルポリシロキサン、メチルフェニルポリシロキサン等、環状ポリシロキサンのデカメチルシクロペンタシロキサン、シクロペンタシロキサン、(ジメチコン/ビニルジメチコン)クロスポリマー等が挙げられる。
保湿剤としては、グリセリン、ジグリセリン、1,3−ブチレングリコール、ジプロピレングリコール、ペンチレングリコール等が挙げられる。
増粘剤としては、(ジメチコン/ビニルジメチコン)クロスポリマー等が挙げられる。
塩類としては、塩化ナトリウム、硫酸マグネシウム等が挙げられる。
PH調製剤としては、クエン酸、クエン酸ナトリウム、リン酸、リン酸ナトリウム、水酸化カリウム等が挙げられる。
防腐剤としては、フェノキシエタノール、パラベン等が挙げられる。
アスコルビン酸誘導体としては、L−アスコルビン酸リン酸エステルマグネシウム塩、L−アスコルビン酸リン酸エステルナトリウム塩、2−O−α−D−グルコピラノシル−L−アスコルビン酸等が挙げられる。
セラミドとしては、セチルPGヒドロキシエチルパルミタイド、セレブロシド等が挙げられる。
Examples of the oil agent include fats and oils such as ester oil and vegetable oil, hydrocarbons, higher fatty acids, higher alcohols, and silicone oils.
Examples of ester oils include cetyl ethylhexanoate, 1,3-butylene glycol diisononanoate, 1,3-butylene glycol di-2-ethylhexanoate, dipropylene glycol diisononanoate, dipropylene glycol di-2-ethylhexanoate, Examples include isononyl isononanoate, glyceryl tri-2-ethylhexanoate, glyceryl tricaprate, glyceryl triisostearate, neopentyl glycol dicaprate, ethylhexyl palmitate, isostearyl neopentanoate, and the like.
Examples of the fats and oils include camellia oil, evening primrose oil, macadamia nut oil, olive oil, rapeseed oil, corn oil, sesame oil, jojoba oil, germ oil, wheat germ oil, and other liquid oils, cocoa butter, coconut oil, and hardened coconut oil. , Solid oils such as palm oil, palm kernel oil, mole owl, owl kernel oil, hydrogenated oil, hydrogenated castor oil, waxes such as beeswax, candelilla wax, cotton wax, nuka wax, lanolin, lanolin acetate, liquid lanolin, sugarcane wax Is mentioned.
Examples of the hydrocarbons include liquid paraffin, squalene, squalane, and microcrystalline wax.
Examples of the higher fatty acid include lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and the like.
Examples of the higher alcohol include linear alcohols such as lauryl alcohol, stearyl alcohol, cetyl alcohol, and cetostearyl alcohol, branched alcohols such as monostearyl glycerin ether, lanolin alcohol, cholesterol, phytosterol, and octyldodecanol. .
Examples of the silicone oil include linear polysiloxanes such as dimethylpolysiloxane and methylphenylpolysiloxane, cyclic polysiloxanes such as decamethylcyclopentasiloxane, cyclopentasiloxane, and (dimethicone / vinyl dimethicone) crosspolymer.
Examples of the humectant include glycerin, diglycerin, 1,3-butylene glycol, dipropylene glycol, and pentylene glycol.
Examples of the thickener include (dimethicone / vinyl dimethicone) crosspolymer.
Examples of the salts include sodium chloride and magnesium sulfate.
Examples of the pH adjusting agent include citric acid, sodium citrate, phosphoric acid, sodium phosphate, potassium hydroxide and the like.
Examples of the preservative include phenoxyethanol and paraben.
Examples of the ascorbic acid derivative include L-ascorbic acid phosphate magnesium salt, L-ascorbic acid phosphate sodium salt, 2-O-α-D-glucopyranosyl-L-ascorbic acid and the like.
Examples of ceramide include cetyl PG hydroxyethyl palmitate, cerebroside and the like.
本発明の油中水型乳化組成物は乳液、クリーム、美容液、日焼け止め、リキッドファンデーション等の化粧料や、皮膚外用剤として医薬部外品や医薬品として使用することができる。 The water-in-oil emulsified composition of the present invention can be used as a quasi-drug or pharmaceutical as cosmetics such as milky lotion, cream, cosmetic liquid, sunscreen, liquid foundation, etc., or as a skin external preparation.
〔実施例〕
表1、2、3の組成にて、実施例1〜10、比較例1〜17の油中水型乳化組成物を、下記調製方法により調製した。
〔Example〕
In the compositions of Tables 1, 2, and 3, water-in-oil emulsion compositions of Examples 1 to 10 and Comparative Examples 1 to 17 were prepared by the following preparation method.
(調製方法)
油相と水相をそれぞれ別に80℃に加熱して、十分に攪拌後、水相を油相へ添加し、ホモミキサーで6000rpm、2分攪拌して乳化し、その後、室温まで攪拌冷却する。尚、本発明の(A)成分は油相に、(B)成分は水相に配合する。
(Preparation method)
The oil phase and the water phase are separately heated to 80 ° C. and sufficiently stirred, and then the water phase is added to the oil phase, emulsified by stirring at 6000 rpm for 2 minutes with a homomixer, and then stirred and cooled to room temperature. In addition, (A) component of this invention is mix | blended with an oil phase, and (B) component is mix | blended with an aqueous phase.
〔油中水型乳化組成物の評価〕
実施例1〜10、比較例1〜17の油中水型乳化組成物について粘度を測定し、乳化状態を顕微鏡で観察した。測定方法などの詳細を以下に示す。
[Evaluation of water-in-oil emulsion composition]
The viscosity was measured about the water-in-oil type emulsion composition of Examples 1-10 and Comparative Examples 1-17, and the emulsification state was observed with the microscope. Details of the measurement method and the like are shown below.
(試作翌日の粘度)
得られた油中水型乳化組成物を直径約3cmのガラス容器に充填し25℃に保存して、調製翌日の粘度を測定(B型粘度計、4号ローター、12rpm、30秒)した。
(Viscosity the day after the prototype)
The obtained water-in-oil emulsion composition was filled in a glass container having a diameter of about 3 cm and stored at 25 ° C., and the viscosity of the day after preparation was measured (B-type viscometer, No. 4, rotor, 12 rpm, 30 seconds).
(保管温度における粘度)
得られた油中水型乳化組成物を直径約3cmのガラス容器に充填し、5℃、25℃、40℃、50℃に7日間保存し、各温度の保管庫から取り出した直後に粘度を測定(B型粘度計、4号ローター、12rpm、30秒)した。
(Viscosity at storage temperature)
The obtained water-in-oil emulsion composition was filled into a glass container having a diameter of about 3 cm, stored at 5 ° C., 25 ° C., 40 ° C., and 50 ° C. for 7 days. Measurement (B-type viscometer, No. 4, rotor, 12 rpm, 30 seconds) was performed.
(保管温度から室温にもどした場合の粘度)
得られた油中水型乳化組成物を直径約3cmのガラス容器に充填し、5℃、25℃、40℃、50℃に7日間保存し、各温度の保管庫から取り出したのち、室温(25℃)にもどしてから粘度を測定(B型粘度計、4号ローター、12rpm、30秒)した。
(Viscosity when returned from storage temperature to room temperature)
The obtained water-in-oil emulsion composition was filled into a glass container having a diameter of about 3 cm, stored at 5 ° C., 25 ° C., 40 ° C., and 50 ° C. for 7 days. The viscosity was measured (B-type viscometer, No. 4, rotor, 12 rpm, 30 seconds).
室温(25℃)と各保管温度(5℃、40℃、50℃)での粘度の差が小さいと、使用時の環境(外気温)に影響されずに常に一定の使用感(粘度)の油中水型乳化組成物を提供できると判断した。
保管温度による粘度の変化を評価するために、下記式により室温(25℃)に対する各保管温度(5℃、40℃、50℃)の粘度の比を計算した。値が1に近いほど粘度の変化が小さい優れた乳化組成物であることになる。
粘度比A=各保管温度での粘度÷25℃の粘度
When the difference in viscosity between room temperature (25 ° C) and each storage temperature (5 ° C, 40 ° C, 50 ° C) is small, the feeling of use (viscosity) is always constant without being affected by the environment (outside temperature) during use. It was determined that a water-in-oil emulsion composition could be provided.
In order to evaluate the change in viscosity due to storage temperature, the ratio of the viscosity of each storage temperature (5 ° C., 40 ° C., 50 ° C.) to room temperature (25 ° C.) was calculated according to the following formula. The closer the value is to 1, the better the emulsion composition with less change in viscosity.
Viscosity ratio A = Viscosity at each storage temperature ÷ 25 ° C viscosity
また、保管温度から室温(25℃)に戻した場合の粘度についても同様に、下記式により粘度の比を計算した。値が1に近いほど保管温度により組成物が変化しない優れた乳化組成物であることになる。
粘度比B=各保管温度から室温に戻した時の粘度÷25℃の粘度
Similarly, for the viscosity when the storage temperature was returned to room temperature (25 ° C.), the ratio of the viscosity was calculated by the following formula. The closer the value is to 1, the better the emulsified composition that the composition does not change with storage temperature.
Viscosity ratio B = viscosity when each storage temperature is returned to room temperature / viscosity of 25 ° C.
(顕微鏡観察)
OLYMPUS社製のシステム偏光顕微鏡BX-50-33P-Dを用いて25℃に1日間保存した油中水型乳化組成物を倍率400で観察し、下記の基準で判定した。
◎;粒子径が細かく均一である
○;粒子径が細かくはないが均一である
△;粒子径が不揃である
×;粒子径が揃っておらず、合一が見られる
(Microscopic observation)
The water-in-oil emulsion composition stored at 25 ° C. for 1 day was observed with a system polarization microscope BX-50-33P-D manufactured by OLYMPUS at a magnification of 400 and judged according to the following criteria.
◎: Particle size is fine and uniform ○: Particle size is not fine but uniform △: Particle size is uneven ×: Particle size is not uniform and unification is seen
尚、表1〜3の組成において、成分名の横に*マークが付与されたものは、下記の市販品を用いたことをあらわしている。
*1 クローダジャパン株式会社製の「シスロールDPHS」
*2 昭和電工株式会社製の「ビタミンEリン酸ナトリウム」
*3 味の素株式会社製の「エルデュウAPS−307」
*4 信越化学工業株式会社製の「KSG−15」
*5 チバ・ジャパン株式会社「Tinocare Gl」
*6 キレトス株式会社製の「キレトス2C−SD」
*7 エボニックデグサジャパン株式会社製の「ISOLAN GPS」
*8 日光ケミカルズ株式会社製の「NIKKOL Hexaglyn PR-15」
*9 日光ケミカルズ株式会社製の「NIKKOL DGMIS」
*10成和化成株式会社製の「プロテシル FN」
*11花王株式会社製の「ペネトール GE−IS」
*12花王株式会社製の「エキセパール IS−CE−A」
In addition, in the composition of Tables 1-3, what was given * mark beside the ingredient name shows that the following commercial item was used.
* 1 “Cisroll DPHS” manufactured by Croda Japan Co., Ltd.
* 2 “Vitamin E sodium phosphate” manufactured by Showa Denko KK
* 3 “El Dew APS-307” manufactured by Ajinomoto Co., Inc.
* 4 “KSG-15” manufactured by Shin-Etsu Chemical Co., Ltd.
* 5 Ciba Japan Co., Ltd. “Tinocare Gl”
* 6 “Kiretos 2C-SD” manufactured by Kiretos Co., Ltd.
* 7 “ISOLAN GPS” manufactured by Evonik Degussa Japan
* 8 “NIKKOL Hexaglyn PR-15” manufactured by Nikko Chemicals Corporation
* 9 "NIKKOL DGMIS" manufactured by Nikko Chemicals Co., Ltd.
* 10 Protecil FN manufactured by Seiwa Kasei Co., Ltd.
* 11 “Penator GE-IS” manufactured by Kao Corporation
* 12 “Exepar IS-CE-A” manufactured by Kao Corporation
本発明の油中水型乳化組成物を評価した結果を表1に示す。
尚、表中のマイナス(−)とは、測定していないことを表しており、×とは乳化できなかったことを表している。
The results of evaluating the water-in-oil emulsion composition of the present invention are shown in Table 1.
In addition, the minus (-) in a table | surface represents not having measured, and x represents having been unable to emulsify.
(A)成分であるジポリヒドロキシステアリン酸PEG−30で乳化した比較例1の乳化組成物は粘度が2100mPa・sであり、低めの粘度であった。
(A)成分であるジポリヒドロキシステアリン酸PEG−30で乳化した油中水型乳化組成物に、化粧料の増粘剤として一般的に用いられる親油性増粘剤(水添ポリイソブテン、パルミチン酸デキストリン、(ベヘン酸/エイコサン二酸)グリセリル、(ジメチコン/ビニルジメチコン)クロスポリマー、親水性増粘剤(キサンタンガム、スクレロチウムガム)を配合してみたが、増粘効果はいずれも低かった(比較例4、5、7〜13)。
親油性増粘剤である(ジメチコン/ビニルジメチコン)クロスポリマーを配合した比較例5、親油性増粘剤である(ジメチコン/ビニルジメチコン)クロスポリマーと(ベヘン酸/エイコサン二酸)グリセリルを配合した比較例9は、本試験の中では比較的増粘した組成であるが、得られた油中水型乳化組成物の粘度は4500mPa・sであり、増粘剤を含まない比較例1の組成物の2100mPa・sの約2倍程度までしか増粘できなかった。
The emulsified composition of Comparative Example 1 emulsified with component (A), dipolyhydroxystearic acid PEG-30, had a viscosity of 2100 mPa · s, which was a lower viscosity.
(A) Lipophilic thickener (hydrogenated polyisobutene, palmitic acid) generally used as a thickener for cosmetics in a water-in-oil emulsion composition emulsified with PEG-30, a dipolyhydroxystearic acid component Dextrin, (behenic acid / eicosanedioic acid) glyceryl, (dimethicone / vinyl dimethicone) crosspolymer, and hydrophilic thickener (xanthan gum, sclerotium gum) were blended, but the thickening effect was low ( Comparative Examples 4, 5, 7-13).
Comparative Example 5 blended with (dimethicone / vinyl dimethicone) crosspolymer, which is a lipophilic thickener, blended with (dimethicone / vinyl dimethicone) crosspolymer, which is a lipophilic thickener, and glyceryl (behenic acid / eicosanedioic acid) Comparative Example 9 has a relatively thickened composition in this test, but the viscosity of the obtained water-in-oil emulsion composition is 4500 mPa · s, and the composition of Comparative Example 1 does not contain a thickener. The viscosity could only be increased up to about twice the 2100 mPa · s of the product.
比較例3および比較例6は、親水性増粘剤、親油性増粘剤のどちらも含まず、電解質として硫酸マグネシウム、L−アスコルビルリン酸マグネシウム塩、クエン酸および水酸化カリウムを含んでいる。
これは、油中水型乳化組成において、電解質を含ませると増粘するという知見に基づいて行った試験である。
硫酸マグネシウムを配合した比較例3の粘度は2850mPa・s、L−アスコルビルリン酸マグネシウム塩および水酸化カリウムを配合した比較例6の粘度は4500mPa・sであり、期待したほどの増粘効果は得られなかった。
これに対して、トコフェリルリン酸ナトリウムを配合した実施例1〜5は、それぞれ14550mPa・s、11400mPa・s、21600mPa・s、7600mPa・s、16750mPa・sと高い粘度が得られている。
共通の油剤を用いた実施例1と比較例3〜12を比較すると、トコフェリルリン酸ナトリウムを配合することによって、粘度が3〜10倍に増大することがわかる。
実施例1〜5は、比較例1〜5、11,12と同様に、べたつかず、さっぱりとした使用感を有するが、その使用感を維持したまま粘度が増大しており、使用感に優れ、高級感に優れるクリームが実現された。さらに、粘性に劣る比較例6〜8は親油性増粘剤の影響により、かえって、べたつきの大きい使用感であった。
Comparative Example 3 and Comparative Example 6 contain neither a hydrophilic thickener nor a lipophilic thickener, and contain magnesium sulfate, L-ascorbyl magnesium salt, citric acid and potassium hydroxide as the electrolyte.
This is a test carried out based on the knowledge that the water-in-oil emulsion composition increases the viscosity when an electrolyte is included.
The viscosity of Comparative Example 3 in which magnesium sulfate was blended was 2850 mPa · s, and the viscosity of Comparative Example 6 in which L-ascorbyl phosphate magnesium salt and potassium hydroxide were blended was 4500 mPa · s. I couldn't.
On the other hand, Examples 1-5 which mix | blended sodium tocopheryl phosphate have high viscosity with 14550 mPa * s, 11400 mPa * s, 21600 mPa * s, 7600 mPa * s, and 16750 mPa * s, respectively.
When Example 1 using a common oil agent and Comparative Examples 3 to 12 are compared, it can be seen that the viscosity increases 3 to 10 times by adding sodium tocopheryl phosphate.
Examples 1 to 5 are not sticky and have a refreshing feeling as in Comparative Examples 1 to 5, 11 and 12, but the viscosity is increased while maintaining the feeling of use, and the feeling of use is excellent. A high-quality cream was realized. Furthermore, Comparative Examples 6-8, which are inferior in viscosity, were rather sticky to use due to the influence of the lipophilic thickener.
(A)成分を含まない比較例2は乳化しなかった。(B成分)を含まない比較例1の油中水型乳化組成物は14日目に観察すると50℃で保存したものが分離していた。
実施例1〜5は30日保存後もすべての保管温度(5℃、25℃、40℃、50℃)で分離がみられず安定であった。
本発明の構成に、さらに、成分(C)のキレート剤であるエデト酸三ナトリウムを含ませた実施例2の油中水型乳化組成物は、保管温度による粘度の差が最も小さかった。
使用時の環境が過酷(外気温が低い、或いは高い)であることが想定される場合には、使用環境に影響されずに常に一定の使用感(粘度)の皮膚外用剤を提供するために、本発明の構成に、さらに、キレート剤を含有させることが有効であることが分かった。
Comparative Example 2 containing no component (A) was not emulsified. When observed on the 14th day, the water-in-oil emulsified composition of Comparative Example 1 not containing (Component B) was separated from the one stored at 50 ° C.
Examples 1 to 5 were stable without separation at all storage temperatures (5 ° C, 25 ° C, 40 ° C, 50 ° C) even after 30 days of storage.
The water-in-oil emulsion composition of Example 2 in which the composition of the present invention further contained trisodium edetate as the chelating agent of component (C) had the smallest difference in viscosity depending on the storage temperature.
To provide a skin external preparation with a constant feeling of use (viscosity) without being affected by the use environment when the environment during use is assumed to be severe (the outside air temperature is low or high). It has been found that it is effective to further contain a chelating agent in the constitution of the present invention.
次に、比較例1の組成に、(B)成分であるトコフェリルリン酸ナトリウムを追加配合した表2の組成にて、実施例6〜10の油中水型乳化組成物を調製した。これは、(B)成分であるトコフェリルリン酸ナトリウムの配合量の違いが粘度にどのように影響するか調べた実験である。結果を表2に示す。 Next, the water-in-oil emulsion compositions of Examples 6 to 10 were prepared with the composition shown in Table 2 in which sodium tocopheryl phosphate as the component (B) was added to the composition of Comparative Example 1. This is an experiment for examining how the difference in the blending amount of sodium tocopheryl phosphate as the component (B) affects the viscosity. The results are shown in Table 2.
トコフェリルリン酸ナトリウムの配合量を増加させると、それに応じて粘度が高くなった(実施例6〜10)。 When the amount of sodium tocopheryl phosphate was increased, the viscosity increased accordingly (Examples 6 to 10).
表3の組成にて、比較例14〜17の油中水型乳化組成物を調製した。
本試験は、(A)成分であるジポリヒドロキシステアリン酸PEG−30を含まずに、その他の界面活性剤と(B)成分であるトコフェリルリン酸ナトリウムを組み合わせた油中水型乳化組成物の粘度を確認するために行った。本試験で用いた界面活性剤は、油中水型乳化組成物調製用として市販されているものである。
結果を表3に示す。
Water-in-oil emulsion compositions of Comparative Examples 14 to 17 were prepared with the compositions shown in Table 3.
This test is a water-in-oil emulsion composition that does not contain dipolyhydroxystearic acid PEG-30 as component (A) and combines other surfactants with sodium tocopheryl phosphate as component (B). This was done to confirm the viscosity of The surfactant used in this test is commercially available for preparing a water-in-oil emulsion composition.
The results are shown in Table 3.
ジポリヒドロキシステアリン酸PEG−30を含まずに、他の界面活性剤とトコフェリルリン酸ナトリウムを組み合わせた比較例14、15の油中水型乳化組成物は、乳化したが粘度が低く1日後に分離した。
比較例16、17は乳化しなかった。
The water-in-oil emulsified compositions of Comparative Examples 14 and 15, which do not contain dipolyhydroxystearic acid PEG-30 and are combined with other surfactants and sodium tocopheryl phosphate, were emulsified but had a low viscosity for 1 day. Separated later.
Comparative Examples 16 and 17 were not emulsified.
以上のことから、本発明のジポリヒドロキシステアリン酸PEG−30とトコフェリルリン酸ナトリウムとを組み合わせることでべたつきのないさっぱりとした使用感を維持しながら、油中水型乳化組成物の粘度を増大させることが出来ることがわかった。
また、この増粘作用は、ジポリヒドロキシステアリン酸PEG−30とトコフェリルリン酸ナトリウムとの組み合わせによる特異な現象であることがわかった。
本発明のジポリヒドロキシステアリン酸PEG−30とトコフェリルリン酸ナトリウムとを組み合わせた油中水型乳化組成物は、ごわついた皮膜感のない優れた使用感であり、粘度の高い高級感のあるクリームを実現できた。
本発明により粘度を上昇させた油中水型乳化組成物は、保管温度による粘度の差が小さいので、乳液やクリームなどの皮膚外用剤として有用である。
表1、表2の結果から、実施例では翌日粘度が7500〜22000mPa・sであり、7日室温経過後6200〜22000であって、大きな変動は認められない。輸送や保管を考慮した温度環境変化を経た後、使用温度である室温(25℃)に戻した場合の粘度変化は、1.5〜0.8であって、安定している。
低温ヒステリシスは、粘度増の傾向が見られ、高温ヒステリシスは低粘度化の傾向がある。5℃経過後25℃に戻した場合、8000〜22850mPa・sであり、50℃から25℃に戻した場合、6300〜18900mPa・sであるので、十分小さな粘度変化範囲にある。この範囲であれば、需要者に対して一定の品質を提供することができる。
これに対して、比較例では5000mPa・sであって、且つ、恒温7日間保存では2.7〜0.5、室温に戻した状態では1.9〜0.4と粘度変化が大きく、温度変化による粘度の安定性に欠くことが分かる。
From the above, the viscosity of the water-in-oil emulsion composition is maintained while maintaining a refreshing feeling without stickiness by combining the dipolyhydroxystearic acid PEG-30 of the present invention and sodium tocopheryl phosphate. It was found that it can be increased.
It was also found that this thickening action is a unique phenomenon due to the combination of dipolyhydroxystearate PEG-30 and sodium tocopheryl phosphate.
The water-in-oil emulsion composition comprising the PEG-30 dipolyhydroxystearate of the present invention and sodium tocopheryl phosphate has an excellent feeling of use without a dull film feeling and a high-class feeling with high viscosity. I was able to realize a cream with.
The water-in-oil emulsion composition having an increased viscosity according to the present invention has a small difference in viscosity depending on the storage temperature, and is therefore useful as an external preparation for skin such as an emulsion or cream.
From the results of Tables 1 and 2, in the examples, the next day viscosity is 7500 to 22000 mPa · s, 6200 to 22000 after the passage of room temperature for 7 days, and no significant fluctuation is observed. The viscosity change is 1.5 to 0.8 and is stable when it is returned to room temperature (25 ° C.), which is the use temperature, after undergoing a temperature environment change considering transportation and storage.
Low temperature hysteresis tends to increase viscosity, and high temperature hysteresis tends to decrease viscosity. When it is returned to 25 ° C. after 5 ° C., it is 8000 to 22850 mPa · s, and when it is returned from 50 ° C. to 25 ° C., it is 6300 to 18900 mPa · s. If it is this range, a fixed quality can be provided with respect to a consumer.
On the other hand, the viscosity is 5000 mPa · s in the comparative example, and is 2.7 to 0.5 when stored at a constant temperature for 7 days, and 1.9 to 0.4 when returned to room temperature. It can be seen that the viscosity stability due to the change is lacking.
処方例1 乳液
(配合成分) (質量%)
1. ジポリヒドロキシステアリン酸PEG−30 1
2. ミリストイルメチル−β−アラニン(フィトステリル
/デシルテトラデシル) 2
3. オリーブ油 5
4. ホホバ油 4
5. パルミチン酸エチルヘキシル 3
6. セチルPGヒドロキシエチルパルミタミド 0.5
7. トリエチルヘキサノイン 1
8. (ジメチコン/ビニルジメチコン)クロスポリマー 1
9. グリセリン 5
10.ペンチレングリコール 2
11.フェノキシエタノール 0.2
12.トコフェリルリン酸ナトリウム 3
13.精製水 残余
(製法)
油相(1〜8)と水相(9〜13)をそれぞれ別に80℃に加熱して、十分に攪拌後、水相を油相へ添加し、ホモミキサーで6000rpm、2分攪拌して乳化し、その後、室温まで攪拌冷却する。
Formulation Example 1 Emulsion
(Compounding ingredients) (mass%)
1. Dipolyhydroxystearic acid PEG-30 1
2. Myristoylmethyl-β-alanine (phytosteryl / decyltetradecyl) 2
3. Olive oil 5
4). Jojoba oil 4
5. Ethyl hexyl palmitate 3
6). Cetyl PG hydroxyethyl palmitamide 0.5
7). Triethylhexanoin 1
8). (Dimethicone / Vinyl Dimethicone) Cross Polymer 1
9. Glycerin 5
10. Pentylene glycol 2
11. Phenoxyethanol 0.2
12 Sodium tocopheryl phosphate 3
13. Purified water residue
(Manufacturing method)
The oil phase (1-8) and the water phase (9-13) are separately heated to 80 ° C. and sufficiently stirred, and then the water phase is added to the oil phase and emulsified by stirring at 6000 rpm for 2 minutes with a homomixer. Then, the mixture is stirred and cooled to room temperature.
処方例1の乳液は、心地よい使用感であり、保存安定性に優れていた。 The emulsion of Formulation Example 1 had a pleasant feeling of use and was excellent in storage stability.
処方例2 クリーム
(配合成分) (質量%)
1. ジポリヒドロキシステアリン酸PEG−30 2
2. ミリストイルメチル−β−アラニン(フィトステリル
/デシルテトラデシル) 2
3. オリーブ油 3
4. ホホバ油 1
5. パルミチン酸エチルヘキシル 2
6. セチルPGヒドロキシエチルパルミタミド 0.5
7. 2−エチルヘキサン酸セチル 1
8. ジメチコン 1
9. ジグリセリン 5
10.ペンチレングリコール 2
11.フェノキシエタノール 0.2
12.トコフェリルリン酸ナトリウム 3
13.精製水 残余
(製法)
油相(1〜8)と水相(9〜13)をそれぞれ別に80℃に加熱して、十分に攪拌後、水相を油相へ添加し、ホモミキサーで6000rpm、2分攪拌して乳化し、その後、室温まで攪拌冷却する。
Formulation Example 2 Cream
(Compounding ingredients) (mass%)
1. Dipolyhydroxystearic acid PEG-30 2
2. Myristoylmethyl-β-alanine (phytosteryl / decyltetradecyl) 2
3. Olive oil 3
4). Jojoba oil 1
5. Ethyl hexyl palmitate 2
6). Cetyl PG hydroxyethyl palmitamide 0.5
7). Cetyl 2-ethylhexanoate 1
8). Dimethicone 1
9. Diglycerin 5
10. Pentylene glycol 2
11. Phenoxyethanol 0.2
12 Sodium tocopheryl phosphate 3
13. Purified water residue
(Manufacturing method)
The oil phase (1-8) and the water phase (9-13) are separately heated to 80 ° C. and sufficiently stirred, and then the water phase is added to the oil phase and emulsified by stirring at 6000 rpm for 2 minutes with a homomixer. Then, the mixture is stirred and cooled to room temperature.
処方例2のクリームは、心地よい使用感であり、保存安定性に優れていた。 The cream of Formulation Example 2 had a pleasant feeling of use and was excellent in storage stability.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010284659A JP5662794B2 (en) | 2010-12-21 | 2010-12-21 | Water-in-oil emulsion composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010284659A JP5662794B2 (en) | 2010-12-21 | 2010-12-21 | Water-in-oil emulsion composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012131733A JP2012131733A (en) | 2012-07-12 |
JP5662794B2 true JP5662794B2 (en) | 2015-02-04 |
Family
ID=46647778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010284659A Active JP5662794B2 (en) | 2010-12-21 | 2010-12-21 | Water-in-oil emulsion composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5662794B2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6122646B2 (en) * | 2013-01-23 | 2017-04-26 | 昭和電工株式会社 | Topical skin preparation |
JP6116258B2 (en) * | 2013-01-23 | 2017-04-19 | 昭和電工株式会社 | External preparation for skin and method for producing the same |
JP6474744B2 (en) * | 2016-01-29 | 2019-02-27 | 株式会社ナリス化粧品 | Water-in-oil emulsified cosmetic |
JP6474743B2 (en) * | 2016-01-29 | 2019-02-27 | 株式会社ナリス化粧品 | Water-in-oil emulsified cosmetic |
JP7580216B2 (en) | 2019-07-19 | 2024-11-11 | 株式会社コーセー | Combination makeup cosmetics |
WO2024142911A1 (en) * | 2022-12-28 | 2024-07-04 | 株式会社 資生堂 | Water-in-oil emulsion cosmetic |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3035742B2 (en) * | 1990-11-30 | 2000-04-24 | 昭和電工株式会社 | Cosmetics |
JP2002308962A (en) * | 2001-04-11 | 2002-10-23 | Pola Chem Ind Inc | Emulsified composition |
JP2004182718A (en) * | 2002-10-11 | 2004-07-02 | Kose Corp | Emulsion cosmetic of water-in-oil type |
JP3993505B2 (en) * | 2002-11-14 | 2007-10-17 | 株式会社コーセー | Water-in-oil emulsified cosmetic |
JP4332062B2 (en) * | 2004-04-23 | 2009-09-16 | 株式会社コーセー | Water-in-oil whitening cosmetic |
JP4781855B2 (en) * | 2006-03-08 | 2011-09-28 | 日本メナード化粧品株式会社 | Composite powder and makeup cosmetic containing the composite powder |
JP2009536949A (en) * | 2006-05-11 | 2009-10-22 | エア プロダクツ アンド ケミカルズ インコーポレイテッド | Personal care compositions containing functional polymers |
JP5296571B2 (en) * | 2008-02-27 | 2013-09-25 | 株式会社ファンケル | Stringed micelle forming composition |
-
2010
- 2010-12-21 JP JP2010284659A patent/JP5662794B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2012131733A (en) | 2012-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6010418B2 (en) | Emulsified composition | |
JP4341983B2 (en) | Topical skin preparation | |
US9839588B2 (en) | Skin external preparation comprising an aqueous dispersion of finely dispersed wax, nonionic surfactant, and ionic water-soluble thickener | |
JP6281744B2 (en) | Oil-in-water emulsified cosmetic | |
JP5662794B2 (en) | Water-in-oil emulsion composition | |
JP6339376B2 (en) | Cosmetics | |
JP6364322B2 (en) | Cosmetic or skin preparation | |
JP2015174849A (en) | Makeup cosmetics | |
JP6133618B2 (en) | Water-in-oil emulsion composition | |
JP2012206986A (en) | Water-in-oil emulsified cosmetic | |
JP2011213601A (en) | Oil-in-water type emulsion cosmetic | |
JP6116966B2 (en) | Oily composition | |
JP5869296B2 (en) | Water-in-oil emulsion composition | |
JP2011026231A (en) | Stick composition and stick product | |
JP2016190841A (en) | Liquid oily cosmetic | |
JP6918548B2 (en) | Topical skin or cosmetics | |
JP5777859B2 (en) | Emulsified composition | |
JP5662750B2 (en) | Water-in-oil emulsion composition | |
JP2010006726A (en) | Skin cosmetic | |
JP5824323B2 (en) | Water-in-oil emulsion composition | |
TW202308591A (en) | Cosmetic | |
JP2003267830A (en) | Liquid cosmetic | |
JP6081097B2 (en) | Oil-in-water emulsion composition | |
JP2013091620A (en) | Water-in-oil type emulsion composition | |
JP5999903B2 (en) | Liquid cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130718 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140320 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140401 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140519 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141202 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141205 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5662794 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |